Briefs: Zydus Lifesciences and Divi's Laboratories
Zydus receives final approval from USFDA for its NDA Zituvimeta, extended-release tablets
Zydus receives final approval from USFDA for its NDA Zituvimeta, extended-release tablets
Kwality Pharma already has registration of 20 molecules from the units and 20 are under registration
Shoff brings over 30 years of international experience in in vitro diagnostics, healthcare distribution and veterinary diagnostics
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Dyslipidemia is a critical risk factor for cardiovascular diseases
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
States urged to maintain a state of constant vigil through screening of pregnant women for Zika virus infection and monitoring the growth of foetus of expecting mothers who tested positive for Zika
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles
Subscribe To Our Newsletter & Stay Updated